These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12808788)

  • 21. Global programme to eliminate lymphatic filariasis: progress report for 2012.
    Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
    [No Abstract]   [Full Text] [Related]  

  • 22. Global programme to eliminate lymphatic filariasis: progress report, 2011.
    Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
    [No Abstract]   [Full Text] [Related]  

  • 23. Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole.
    Selve BP; Bwadua S; Misa M; James K; Usurup JP; Turner P; Melrose W; Yad W; Samuel R; Eddie C
    P N G Med J; 2000; 43(3-4):183-7. PubMed ID: 11939299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elimination of lymphatic filariasis in India.
    Sabesan S; Ravi R; Das PK
    Lancet Infect Dis; 2005 Jan; 5(1):4-5. PubMed ID: 15620551
    [No Abstract]   [Full Text] [Related]  

  • 25. The end of lymphatic filariasis?
    Bockarie MJ; Molyneux DH
    BMJ; 2009 May; 338():b1686. PubMed ID: 19439451
    [No Abstract]   [Full Text] [Related]  

  • 26. Towards elimination of lymphatic filariasis: social mobilization issues and challenges in mass drug administration with anti-filarial drugs in Tamil Nadu, South India.
    Nandha B; Krishnamoorthy K; Jambulingam P
    Health Educ Res; 2013 Aug; 28(4):591-8. PubMed ID: 23503571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
    Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
    Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Importance of Partnership in the Rollout of Triple-Drug Therapy to Eliminate Lymphatic Filariasis in the Pacific.
    Rainima-Qaniuci M; Lepaitai HB; Bhagirov R; Padmasiri E; Naseri T; Thomsen R; Won KY; Brant TA; Dodd E; Nua MT; Utu F; Tufa A; Chutaro E; Camacho J; Suiaunoa-Scanlan L; Thean LJ; Mani J; Hardy M; Samuela J; Romani L; Kaldor J; Steer AC; Faktaufon D; Bechu V; Naqio F; Sosene V; Sekihara M; Otaki J; Buhagiar TS; Yajima A
    Am J Trop Med Hyg; 2022 May; 106(5_Suppl):39-47. PubMed ID: 35292579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sustainability of soil-transmitted helminth control following a single-dose co-administration of albendazole and diethylcarbamazine.
    Rajendran R; Mani TR; Munirathinam A; Sunish IP; Abdullah SM; Augustin DJ; Satyanarayana K
    Trans R Soc Trop Med Hyg; 2003; 97(3):355-9. PubMed ID: 15228259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria endemic districts of Andhra Pradesh, India.
    Mukhopadhyay AK; Patnaik SK; Satya Babu P; Rao KN
    J Vector Borne Dis; 2008 Mar; 45(1):73-5. PubMed ID: 18399322
    [No Abstract]   [Full Text] [Related]  

  • 31. Global programme to eliminate lymphatic filariasis: progress report, 2016.
    Wkly Epidemiol Rec; 2017 Oct; 92(40):594-607. PubMed ID: 28984121
    [No Abstract]   [Full Text] [Related]  

  • 32. Mass drug treatment for lymphatic filariasis and onchocerciasis.
    Molyneux DH; Bradley M; Hoerauf A; Kyelem D; Taylor MJ
    Trends Parasitol; 2003 Nov; 19(11):516-22. PubMed ID: 14580963
    [No Abstract]   [Full Text] [Related]  

  • 33. Major progress toward eliminating lymphatic filariasis.
    Ottesen EA
    N Engl J Med; 2002 Dec; 347(23):1885-6. PubMed ID: 12466515
    [No Abstract]   [Full Text] [Related]  

  • 34. Coverage survey for assessing mass drug administration against lymphatic filariasis in Gulbarga district, Karnataka, India.
    Ranganath BG
    J Vector Borne Dis; 2010 Mar; 47(1):61-4. PubMed ID: 20231778
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphatic filariasis elimination programme in India: progress and challenges.
    Ramaiah KD
    Trends Parasitol; 2009 Jan; 25(1):7-8. PubMed ID: 19008150
    [No Abstract]   [Full Text] [Related]  

  • 36. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
    Fischer PU; King CL; Jacobson JA; Weil GJ
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India.
    Babu BV; Rath K; Kerketta AS; Swain BK; Mishra S; Kar SK
    Trans R Soc Trop Med Hyg; 2006 May; 100(5):464-9. PubMed ID: 16288792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphatic filariasis elimination programme in Assam, India, needs change in mass drug administration strategy to target the focus of infection.
    Khan AM
    Indian J Med Res; 2018 Jan; 147(1):7-10. PubMed ID: 29749354
    [No Abstract]   [Full Text] [Related]  

  • 39. Elimination of lymphatic filariasis in Southeast Asia.
    Sudomo M; Chayabejara S; Duong S; Hernandez L; Wu WP; Bergquist R
    Adv Parasitol; 2010; 72():205-33. PubMed ID: 20624533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A triple-drug treatment regimen to accelerate elimination of lymphatic filariasis: From conception to delivery.
    Weil GJ; Jacobson JA; King JD
    Int Health; 2020 Dec; 13(Suppl 1):S60-S64. PubMed ID: 33349879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.